Triple receptor agonism (GLP-1 + GIP + Glucagon) Phase 2 clinical trial data published Weekly administration in research protocols Emerging research compound with significant interest AOD-9604 AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191)
The best peptides for weight loss guide provides comprehensive comparison of these options
Easy measuring: At 3,333 mcg/mL, 1 unit 33.3 mcg on a U-100 syringe (units = mcg 33.33)
Frontiers in pharmacology, 5, 151
Exercise Recommendations While Taking GLP-1 Medications Move your body, but dont overdo it
Safety Considerations, Contraindications, and Who This Treatment Applies To Non-GLP-1 medications carry distinct safety profiles and contraindications requiring careful provider evaluation